skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8102

Biologics: Targets and Therapy

(1,101,177) Views

Editor in Chief Dr Doris Mangiaracina Benbrook

1177-5475

Case report
Efalizumab-induced severe thrombocytopenia can be resolved
Francesca Prignano, F Zanieri, S Mokhtarzadeh, T Lotti
Biologics: Targets and Therapy 2008, 2:923-927
06 November 2008

Original Research
Effect of extended-release niacin on hormone-sensitive lipase and lipoprotein lipase in patients with HIV-associated lipodystrophy syndrome
Dominic C Chow, Anne Tasaki, Jill Ono, Bruce Shiramizu, Scott A Souza
Biologics: Targets and Therapy 2008, 2:917-921
17 November 2008

Other
Rituximab therapy in Greek patients with rheumatoid arthritis
Aristotelis P Tsiakalos, Nestor K Avgoustidis, Haralampos M Moutsopoulos
Biologics: Targets and Therapy 2008, 2:911-916
30 October 2008

Original Research
Use of a decoy peptide to purify p21 activated kinase-1 in cardiac muscle and identification of ceramide-related activation
Yunbo Ke, R John Solaro
Biologics: Targets and Therapy 2008, 2:903-909
21 August 2008

Original Research
Etiology of hypercoagulable state in women with recurrent fetal loss without other causes of miscarriage from Southern Italy: new clinical target for antithrombotic therapy
Maristella D’Uva, Pierpaolo Di Micco, Ida Strina, Antonio Ranieri, Carlo Alviggi, et al
Biologics: Targets and Therapy 2008, 2:897-902
15 October 2008

Original Research
Allium compounds, dipropyl and dimethyl thiosulfinates as antiproliferative and differentiating agents of human acute myeloid leukemia cell lines
Faten Merhi, Jacques Auger, Francine Rendu, Brigitte Bauvois
Biologics: Targets and Therapy 2008, 2:885-895
08 August 2008

Original Research
Association of pro/anti-inflammatory cytokine gene variants in renal transplant patients with allograft outcome and cyclosporine immunosuppressant levels
Parmeet Kaur Manchanda, Anant Kumar, Raj K Sharma, Himanshu Goel, Rama Devi Mittal
Biologics: Targets and Therapy 2008, 2:875-884
18 November 2008

Review
Abatacept in difficult-to-treat juvenile idiopathic arthritis
Jasmin B Kuemmerle-Deschner, SM Benseler
Biologics: Targets and Therapy 2008, 2:865-874
02 February 2009

Review
The insulin-like growth factor system and its receptors: A potential novel anticancer target
Colin R. Lindsay, T R Jeffry Evans
Biologics: Targets and Therapy 2008, 2:855-864
18 September 2008

Review
Differential regulation of the transcriptional activity of the glucocorticoid receptor through site-specific phosphorylation
Raj Kumar, William J Calhoun
Biologics: Targets and Therapy 2008, 2:845-854
07 August 2008

Review
Safety and efficacy of enzyme replacement therapy in the nephropathy of Fabry disease
Fernando C Fervenza, Roser Torra, David G Warnock
Biologics: Targets and Therapy 2008, 2:823-843
13 November 2008

Review
Bevacizumab in the treatment of HER2-negative breast cancer
Vito Lorusso
Biologics: Targets and Therapy 2008, 2:813-821
27 November 2008

Review
Novel microtubule-targeting agents – the epothilones
Kit L Cheng, Thomas Bradley, Daniel R Budman
Biologics: Targets and Therapy 2008, 2:789-811
21 October 2008

Review
Sorafenib for the treatment of unresectable hepatocellular carcinoma
Junji Furuse
Biologics: Targets and Therapy 2008, 2:779-788
16 November 2008

Review
Adalimumab for the treatment of Crohn’s disease
Andrea Cassinotti, Sandro Ardizzone, Gabriele Bianchi Porro
Biologics: Targets and Therapy 2008, 2:763-777
16 September 2008

Review
Therapeutic vaccines for malignant brain tumors
Michael P Gustafson, Keith L Knutson, Allan B Dietz
Biologics: Targets and Therapy 2008, 2:753-761
11 December 2008

Review
α-L-iduronidase therapy for mucopolysaccharidosis type I
Jakub Tolar, Paul J Orchard
Biologics: Targets and Therapy 2008, 2:743-751
28 August 2008

Review
Long term management of patients with cryopyrin-associated periodic syndromes (CAPS): focus on rilonacept (IL-1 Trap)
Leigh D Church, Sinisa Savic, Michael F McDermott
Biologics: Targets and Therapy 2008, 2:733-742
14 October 2008

Review
The target of arachidonic acid pathway is a new anticancer strategy for human prostate cancer
Masahide Matsuyama, Rikio Yoshimura
Biologics: Targets and Therapy 2008, 2:725-732
07 July 2008

Review
Denileukin diftitox for the treatment of cutaneous T-cell lymphoma
David Kaminetzky, Kenneth B Hymes
Biologics: Targets and Therapy 2008, 2:717-724
04 December 2008

Review
Small molecule tyrosine kinase inhibitors in pancreatic cancer
Sachin Gupta, Bassel F El-Rayes
Biologics: Targets and Therapy 2008, 2:707-715
06 October 2008

Review
Microenvironmental considerations in the application of human mesenchymal stem cells in regenerative therapies
Steven J Greco, Pranela Rameshwar
Biologics: Targets and Therapy 2008, 2:699-705
06 October 2008

Original Research
Biological drugs targeting the immune response in the therapy of psoriasis
Saveria Pastore, Emanuela Gubinelli, Luca Leoni, Desanka Raskovic, Liudmila Korkina
Biologics: Targets and Therapy 2008, 2:687-697
07 August 2008

Review
Anticomplement therapy
Prathit A Kulkarni, Vahid Afshar-Kharghan
Biologics: Targets and Therapy 2008, 2:671-685
11 February 2009

Review
Prevention of bone mineral density loss in patients with rheumatoid arthritis treated with anti-TNFα therapy
Hubert Marotte, Pierre Miossec
Biologics: Targets and Therapy 2008, 2:663-669
29 August 2008

Review
Treatment of short stature and growth hormone deficiency in children with somatotropin (rDNA origin)
Dana S Hardin
Biologics: Targets and Therapy 2008, 2:655-661
01 August 2008

Expert Opinion
Denosumab: an investigational drug for the management of postmenopausal osteoporosis
E Michael Lewiecki
Biologics: Targets and Therapy 2008, 2:645-653
04 August 2008

Review
Review of consensus interferon in the treatment of chronic hepatitis C
Th Witthöft
Biologics: Targets and Therapy 2008, 2:635-643
30 September 2008

Review
Rituximab in the treatment of non-Hodgkin’s lymphoma
Beate Hauptrock, Georg Hess
Biologics: Targets and Therapy 2008, 2:619-633
30 September 2008

Review
Review of recombinant human deoxyribonuclease (rhDNase) in the management of patients with cystic fibrosis
Tacjana Pressler
Biologics: Targets and Therapy 2008, 2:611-617
30 September 2008

Review
Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma
Camillo Porta, Chiara Paglino, Luciano Mutti
Biologics: Targets and Therapy 2008, 2:601-609
05 August 2008

Review
Clinical use of topical thrombin as a surgical hemostat
Wesley K Lew, Fred A Weaver
Biologics: Targets and Therapy 2008, 2:593-599
01 August 2008

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University

  • Journal Indexing

    See where all the Dove Press journals are indexed